Redirecting Mouse T Hybridoma Against Human Breast and Ovarian Carcinomas: In Vivo Activity Against HER-2/neu Expressing Cancer Cells

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600888
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas Without HER-2/neu Gene Amplification

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2003English

Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer

Medical Journal Armed Forces India
Medicine
2008English

T Cells Sensitized With Breast Tumor Progenitor Cell Vaccine Have Therapeutic Activity Against Spontaneous HER2/neu Tumors

Breast Cancer Research and Treatment
Cancer ResearchOncology
2011English

Chemosensitization of HER-2/neu-overexpressing Human Breast Cancer Cells to Paclitaxel (Taxol) by Adenovirus Type 5 E1A

Oncogene
Cancer ResearchGeneticsMolecular Biology
1997English

Amplification of Her-2/Neu Gene in Her-2/Neu-Overexpressing and -Nonexpressing Breast Carcinomas and Their Synchronous Benign, Premalignant, and Metastatic Lesions Detected by FISH in Archival Material

Modern Pathology
Forensic MedicinePathology
2002English

HER-2/neu Transcriptionally Activates Jab1 Expression via the AKT/ -Catenin Pathway in Breast Cancer Cells

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Activity of the Multikinase Inhibitor Dasatinib Against Ovarian Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2009English

Evaluating the Anticancer Activity of Hedyotis Diffusa Water Extract Against Human Breast Cancer McF7 Cells

The Open Natural Products Journal
2013English

Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy